SCMFMDA: Predicting microRNA-disease associations based on similarity constrained matrix factorization.
Autor: | Li L; School of Cyber Science and Engineering, Qufu Normal University, Qufu, China., Gao Z; School of Cyber Science and Engineering, Qufu Normal University, Qufu, China., Wang YT; School of Cyber Science and Engineering, Qufu Normal University, Qufu, China., Zhang MW; School of Cyber Science and Engineering, Qufu Normal University, Qufu, China., Ni JC; School of Cyber Science and Engineering, Qufu Normal University, Qufu, China., Zheng CH; School of Cyber Science and Engineering, Qufu Normal University, Qufu, China.; School of Artifial Intelligence, Anhui University, Hefei, China., Su Y; School of Artifial Intelligence, Anhui University, Hefei, China. |
---|---|
Jazyk: | angličtina |
Zdroj: | PLoS computational biology [PLoS Comput Biol] 2021 Jul 12; Vol. 17 (7), pp. e1009165. Date of Electronic Publication: 2021 Jul 12 (Print Publication: 2021). |
DOI: | 10.1371/journal.pcbi.1009165 |
Abstrakt: | miRNAs belong to small non-coding RNAs that are related to a number of complicated biological processes. Considerable studies have suggested that miRNAs are closely associated with many human diseases. In this study, we proposed a computational model based on Similarity Constrained Matrix Factorization for miRNA-Disease Association Prediction (SCMFMDA). In order to effectively combine different disease and miRNA similarity data, we applied similarity network fusion algorithm to obtain integrated disease similarity (composed of disease functional similarity, disease semantic similarity and disease Gaussian interaction profile kernel similarity) and integrated miRNA similarity (composed of miRNA functional similarity, miRNA sequence similarity and miRNA Gaussian interaction profile kernel similarity). In addition, the L2 regularization terms and similarity constraint terms were added to traditional Nonnegative Matrix Factorization algorithm to predict disease-related miRNAs. SCMFMDA achieved AUCs of 0.9675 and 0.9447 based on global Leave-one-out cross validation and five-fold cross validation, respectively. Furthermore, the case studies on two common human diseases were also implemented to demonstrate the prediction accuracy of SCMFMDA. The out of top 50 predicted miRNAs confirmed by experimental reports that indicated SCMFMDA was effective for prediction of relationship between miRNAs and diseases. Competing Interests: The authors have declared that no competing interests exist. |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |